文献速递慢性静脉疾病

局部麻醉下门诊选择性静脉曲张消融术(ASVAL)治疗症状性静脉曲张的系统综述

Systematic review of ambulatory selective variceal ablation under local anesthetic technique for the treatment of symptomatic varicose veins.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-10-31

该系统综述检索Medline、Embase和Cochrane对照试验注册库至2019年5月,纳入11篇原始文章,共1734例患者2106条肢体接受ASVAL干预。1年静脉曲张复发率为0.5%至13.5%,1622条术前诊断大隐静脉(GSV)功能不全的肢体中1114条在1年时功能完好(平均68.2%±12.62%),所有测量GSV直径的研究均报告静脉尺寸有统计学显著缩小。

要点

  • ASVAL可作为伴有主干反流的早期慢性静脉疾病的一种微创治疗选择。
  • 1年静脉曲张复发率范围为0.5%至13.5%,GSV功能恢复平均约68.2%。
  • 现有证据需通过标准化流程的前瞻性随机对照试验加以强化。

核心结论

  • ASVAL可被视为伴有主干反流的早期慢性静脉疾病的一种微创治疗方法。
  • 现有证据基础需通过标准化流程并报告公认生活质量指标的前瞻性随机对照试验来加强。

研究设计与样本

  • 系统综述,检索Medline、Embase和Cochrane对照试验注册库至2019年5月,定性审阅11篇原始文章。
  • 纳入研究包括2项随机对照试验、1项病例对照研究、3项队列研究和5项病例系列。
  • 共1734例患者、2106条肢体接受ASVAL干预。

主要发现

  • 1年静脉曲张复发率在患者中为0.5%至13.5%。
  • 1622条术前诊断GSV功能不全的肢体中,1114条在1年时功能完好(平均68.2%±12.62%)。
  • 所有测量GSV直径的研究均报告静脉尺寸有统计学显著缩小。

关键数值与推荐

  • 主要结局为1年随访时无复发性静脉曲张。
  • 次要结局包括双功超声下GSV反流缓解、GSV直径变化、慢性静脉疾病的客观与主观临床改善及患者报告结局指标。

临床怎么用

  • 对于伴有主干反流的早期慢性静脉疾病,可考虑采用ASVAL作为微创治疗选项。

局限性

  • 证据基础需通过标准化流程并报告公认生活质量指标的前瞻性随机对照试验来加强。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The ambulatory selective variceal ablation under local anesthesia (ASVAL) technique subscribes to the "ascending" theory of varicose vein etiology, which recommends primary ambulatory phlebectomy as a treatment for tributary varicosities and truncal vein incompetence. This systematic review explores the efficacy and safety of the ASVAL technique for the treatment of symptomatic varicose veins. METHODS: A comprehensive search of the Medline and Embase databases and the Cochrane Register of Controlled Trials in May 2019 revealed 11 original articles that were qualitatively reviewed. The primary outcome was the absence from recurrent varicose veins at 1-year follow-up. Secondary outcomes were resolution of great saphenous vein (GSV) reflux on duplex ultrasound, change in GSV diameter, objective and subjective clinical improvement in chronic venous disease, and patient-reported outcome measures. RESULTS: A total of 2106 limbs underwent intervention in 1734 patients reported in two randomized controlled trials, one case control study, three cohort studies, and five case series. Varicosity recurrence at 1 year ranged from 0.5% to 13.5% in patients. Of 1622 limbs with diagnosed GSV incompetence before intervention, 1114 were competent at 1 year (mean, 68.2% [±12.62%]). All studies measuring GSV diameter reported statistically significant reductions in vein size. CONCLUSIONS: ASVAL may be considered as a minimally invasive treatment for early stages of chronic venous disease in the presence of truncal reflux. The evidence base should be strengthened by prospective randomized controlled trials that follow standardized procedures and report according to recognized measures of quality of life alongside clinical and hemodynamic data.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Richards T, Anwar M, Beshr M, et al. Systematic review of ambulatory selective variceal ablation under local anesthetic technique for the treatment of symptomatic varicose veins. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 33137495. doi:10.1016/j.jvsv.2020.10.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。